TCL Archive HHS System Of Misconduct investigation Not Suited For Clinical Trials, Broder Says November 11, 1994
TCL Archive In Brief: Hammer Reappointed chairman; Wyngaarden Names Ferguson of Baylor As OMAR Director July 29, 1988
TCL Archive NCI advisors approved in concept the Institute’s plan to spend $24 million over five years for research on “patient navigator” programs. March 26, 2004
TCL Archive Drug Cleared For GIST And Kidney Cancer, FDA’s First Two-Indication Cancer Approval January 27, 2006
